Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells
Division of Endocrinology
Analysis of Variance; Animals; Cell Line; Ceramides; Cyclic AMP; *Gene Expression Regulation, Enzymologic; Interferon-gamma, Recombinant; Iodide Peroxidase; Kinetics; Protein Kinase C; RNA, Messenger; Rats; Sphingomyelin Phosphodiesterase; Sphingomyelins; Tetradecanoylphorbol Acetate; Thyroid Gland; Thyrotropin; Transcription, Genetic
Life Sciences | Medicine and Health Sciences
Tumor necrosis factor-alpha (TNF alpha) is a pleiotropic cytokine that is involved in the regulation of thyroid growth and differentiated functions. The cellular and molecular mechanisms involved in mediating the effects of TNF alpha on thyroid function, however, are unknown. In a number of cell types, TNF alpha receptor binding results in the activation of specific signal transduction cascades, including protein kinase C (PKC) and the hydrolysis of sphingomyelin to ceramide. In the present study, we examined the possible role of PKC and the hydrolysis of sphingomyelin to ceramide in the regulation of TSH-induced increases in 5'-deiodinase (5'D-I) activity and 5'D-I messenger RNA (mRNA) levels in FRTL-5 cells. Further, we have recently shown that TNF alpha and interferon-gamma (IFN gamma) act synergistically to block TSH-induced increases in type I 5'D-I activity and 5'D-I gene expression in FRTL-5 rat thyroid cells. Thus, we tested the hypothesis that the activation of one or both pathways is involved in synergistic effect of TNF alpha and IFN gamma on thyroid function. In TSH-stimulated FRTL-5 cells, the addition of 12-O-tetradecanoylphorbol 13-acetate (TPA), an activator of PKC, inhibited TSH-induced increases in 5'D-I activity and 5'D-I mRNA levels in a dose-dependent manner. Incubation of FRTL-5 cells with TPA and a minimal effective concentration of IFN gamma (12.5 U/ml) in combination, however, failed to result in a synergistic inhibition of the TSH-induced increase in 5'D-I activity or 5'D-I mRNA levels. Similarly, incubation of FRTL-5 cells with sphingomyelinase (SMase), which converts sphingomyelin to ceramide, inhibited TSH-induced increases in 5'D-I activity and 5'D-I mRNA levels in a dose-dependent manner. Coincubation of FRTL-5 cells with SMase and IFN gamma failed to show a synergistic inhibition of the TSH-induced increase in 5'D-I activity or 5'D-I mRNA levels. Further, incubation of FRTL-5 cells with TPA plus SMase in the presence of IFN gamma failed to result in the synergistic inhibition of TSH-induced increases in 5'D-I activity or 5'D-I mRNA levels. The effect of TPA and SMase on TSH-induced cAMP production was examined. Low concentrations of TPA, which inhibit TSH-induced 5'D-I activity, failed to inhibit TSH-induced cAMP production or the cAMP-induced increase in 5'D-I activity. In contrast, SMase inhibited TSH-induced cAMP production in a dose-dependent manner. In the presence of IFN gamma, however, activation of either or both pathways is not sufficient to result in a synergistic inhibition of 5'D-I activity or 5'D-I gene expression. Together, our results suggest that TNF alpha-induced activation of PKC and hydrolysis of sphingomyelin can inhibit thyroid cell function. The activation of additional signal transduction pathways, however, by TNF alpha is required for the synergistic inhibition of thyroid function by TNF alpha and IFN gamma.
Endocrinology. 1996 Nov;137(11):4994-9.
Mori K, Stone S, Braverman LE, DeVito WJ. (1996). Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells. Open Access Publications by UMMS Authors. Retrieved from https://escholarship.umassmed.edu/oapubs/526